Skip to main
MASI

Masimo (MASI) Stock Forecast & Price Target

Masimo (MASI) Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 20%
Buy 40%
Hold 40%
Sell 0%
Strong Sell 0%

Bulls say

Masimo is an innovative and growing medical technology company that is focused on developing and providing noninvasive patient monitoring technologies, hospital automation and connectivity solutions, and other healthcare products. The company's core business segment, healthcare, is a key revenue driver and is expected to continue to grow due to Masimo's focus on innovation and execution. Their recent investor day showcased their progress in optimizing their cost structure, closing a sale of a non-core business, and highlighting their growth pillars, including focus, innovation and execution. With a target of generating $1B of free cash flow and an expected 30% operating margin, Masimo is well-positioned for long-term success.

Bears say

Masimo is heavily dependent on the healthcare sector for its revenues, putting them at risk of experiencing significant financial challenges if there are any disruptions in the industry. Additionally, their recent refinancing of their credit agreement and focus on growth markets through investment in advanced technologies may not be enough to offset the potential negative impacts on their business. The pending acquisition by Danaher for $9.9B also raises concerns about their future performance and potential for competing bids.

Masimo (MASI) has been analyzed by 5 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 40% recommend Buy, 40% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Masimo and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Masimo (MASI) Forecast

Analysts have given Masimo (MASI) a Buy based on their latest research and market trends.

According to 5 analysts, Masimo (MASI) has a Buy consensus rating as of May 6, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $187.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $187.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Masimo (MASI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.